Interacting Drugs |
Abiraterone vs Everolimus |
Security Level |
|
Mechanism |
Everolimus: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Everolimus. |
Management |
Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma. See prescribing information for specific dose adjustment and monitoring recommendations. |
Abiraterone vs Everolimus
Post Review about Abiraterone vs Everolimus Click here to cancel reply.
Other Interactions of Abiraterone
Other Interactions of Everolimus
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.